ZENITHDRUG Stock Overview
Zenith Drugs Limited operates as a pharmaceutical manufacturing and trading company in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Zenith Drugs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹64.10 |
| 52 Week High | ₹114.50 |
| 52 Week Low | ₹52.80 |
| Beta | 0 |
| 1 Month Change | 2.23% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZENITHDRUG | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 2.2% | 1.8% | 1.6% |
| 1Y | n/a | 57.0% | 45.1% |
Return vs Industry: Insufficient data to determine how ZENITHDRUG performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ZENITHDRUG performed against the Indian Market.
Price Volatility
| ZENITHDRUG volatility | |
|---|---|
| ZENITHDRUG Average Weekly Movement | 10.2% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: ZENITHDRUG's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ZENITHDRUG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 61 | Sandeep Bhardwaj | zenithdrugs.com |
Zenith Drugs Limited operates as a pharmaceutical manufacturing and trading company in India and internationally. The company offers products in the areas of electrolytes, analgesic, antipyretic, NSAIDs, anti-inflammatory, antiemetic, cold, cough, antihistaminic and antiasthmatic, antibacterial, antifungal, anti-infective, antiparasitic, antiviral, anthelmintic, anti-scabies, antimicrobial, antimalarial, disinfectant, antiseptic, corticosteroids, depigmenting agents, gastrointestinal, liver, kidney, skin care, antibiotic preparations, nutrition supplements, and others. It also provides a range of formulations in various forms, such as ORS powder, liquid orals, ointments, creams, gels, tablets, liquid externals, and capsules.
Zenith Drugs Limited Fundamentals Summary
| ZENITHDRUG fundamental statistics | |
|---|---|
| Market cap | ₹1.10b |
| Earnings (TTM) | ₹51.53m |
| Revenue (TTM) | ₹1.15b |
21.3x
P/E Ratio1.0x
P/S RatioIs ZENITHDRUG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZENITHDRUG income statement (TTM) | |
|---|---|
| Revenue | ₹1.15b |
| Cost of Revenue | ₹853.26m |
| Gross Profit | ₹291.94m |
| Other Expenses | ₹240.40m |
| Earnings | ₹51.53m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.01 |
| Gross Margin | 25.49% |
| Net Profit Margin | 4.50% |
| Debt/Equity Ratio | 150.9% |
How did ZENITHDRUG perform over the long term?
See historical performance and comparison